Ann: Letter to Shareholders, page-144

the reality is that results do matter....they are a stepping stone to earnings.....earnings contribute to profits...profits equate to value....
Imugene is the victim of being a market "darling"......the market pushed it beyond where it should have been given its trial time frame,
newbies jumped in dreaming of becoming instant millionaires, sensible posters questioning the surging shareprice were placed on
"ignore" with raucous approval ....Market cap of $135B mentioned .....traders loved it and the good ones made heaps....
sentiment changed to buy which I will look to do in the new year...